Manuel Rodriguez Perez, MD
Orthopaedic Surgery · Bayamon, PRNPI 1588041263
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,153 of the $4,470 with a category attached, or 70.5%. 10 manufacturers reported payments, led by Stryker at 33.4% of the total.
Across 36 payments — averaging $124.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1K
- Encore Medical, LP$1K
- Zimmer Biomet$874
- Biomarin Pharmaceutical Inc.$143
- KCI USA, Inc.$125
- Johnson And Johnson International$103
- plus $249 from 4 others
What the payments were for
- Travel & lodging$1,31729%
- Food & beverage$3,15371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 17 | $1,493 |
| Encore Medical, LP | 8 | $1,484 |
| Zimmer Biomet | 3 | $874 |
| Biomarin Pharmaceutical Inc. | 1 | $143 |
| KCI USA, Inc. | 1 | $125 |
| Johnson And Johnson International | 1 | $103 |
| Medtronic | 1 | $89 |
| Solventum Corporation | 1 | $73 |
| Smith+Nephew | 2 | $58 |
| Axogen | 1 | $29 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO Surgical TaperFill Hip System$1,094
- MAKO$1,022
- DJO SURGICAL$274
- Vimizim$143
- Naglazyme$143
- Brineura$143
- V.A.C. VERAFLO$125
- LCP PLATES & SCREWS$103
How this compares
$4,470 in reported general payments places this provider in the 65th percentile of 94 orthopaedic surgery providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enoxaparin Sodium | 12 | $1,251 |
| Cefadroxil | 92 | $1,021 |
| Celecoxib | 77 | $889 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $472 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 22 | $413 |
| Gabapentin | 87 | $396 |
| Diclofenac Sodium | 30 | $312 |
| Triamcinolone Acetonide | 19 | $191 |
| Ondansetron Hcl | 47 | $172 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Bayamon
- Edil Jimenez-PerezBayamon$14K
- Richard Valentin BlasiniBayamon$13K
- Efrain Deliz AsmarBayamon$5K
- Maritza LoinazBayamon$763
- Alberto Rivera RosadoSanturce$197K
- Andres Muniz MartinezCayey$56K
- David Beaton ComuladaSan Juan$29K
- John KaganHumacao$27K
- Juan Santiago TorresHatillo$24K
- Ariel Davila-ParrillaSan Juan$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.